A CLINICAL TRIAL TO STUDY THE EFFECT OF A DRUG NAMED VIDANGA GHRITHA IN CHILDREN INFECTED WITH WORMS

PHYSICO-CHEMICAL ANALYSIS AND CLINICAL TRIAL TO EVALUATE THE EFFICACY OF VIDANGA GHRITHA IN UDARAKRIMI - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017040

Enrollment

Registered

2019-01-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B80- Enterobiasis Health Condition 2: B761- Necatoriasis Health Condition 3: B880- Other acariasis

Interventions

Intervention1: Vidanga ghritha: 6ml twice daily for 7 days Intervention2: Vidanga ghritha: orally 6ml twice daily for 7 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: -Classical symptoms of krimi Riga -Stool examination positive for presence of ova/cyst/worm of Ascaris lumberjack idea,enterobius vermicularis,necator Americans.

Exclusion criteria

Exclusion criteria: -Stool examination negative for presence of ova/cyst/worm of Ascaris lumbriocoides,enterobius vermicularis,necator Americanus -children with systemic illness

Design outcomes

Primary

Measure	Time frame
Stool examinationTimepoint: 8th day	—

Secondary

Measure	Time frame
Stomach ache,loss of appetite,fever, discoloration, diarrhoea, pruritis aniTimepoint: 8th day	—

Countries

India

Contacts

Public ContactDrGNisha

Amrita school of Ayurveda

drramesh.adiga@gmail.com9446962390

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026